Gene · 994
CDC25B: cell division cycle 25B
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CDC25B: cell division cycle 25B. Genes, record 994. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/994
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P30305 | M-phase inducer phosphatase 2 | 580 | 19 | Ensembl, GeneID, HGNC |
Source UniProt
Patents33
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 40771 | P30305 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 1170 | P30305 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 835 | P30305 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 4427 | P30305 | Espacenet |
| US 12433888 B1 | 2025-10-07 | 11 | P30305 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 835 | P30305 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 1170 | P30305 | Espacenet |
| EP 4555325 A2 | 2025-05-21 | 11 | P30305 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 4427 | P30305 | Espacenet |
| US 11987613 B2 | 2024-05-21 | 11 | P30305 | Espacenet |
1 to 10 of 33
See all 33 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,099
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CDC25B papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 21 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 6 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 5 | 2025 |
| P30CA044579 | University of Virginia Cancer Center Support Grant | 5 | 2025 |
| R01AG011085 | Ubiquitin‐mediated proteolysis and cell cycle control | 5 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 4 | 2025 |
| P30CA036727 | Buffett Cancer Center Support Grant | 4 | 2025 |
| P30CA047904 | Cancer Center Support Grant | 4 | 2025 |
| ZIACP010121 | Molecular Epidemiology Studies of Occupational and Environmental Exposures | 4 | 2025 |
| P01AI127335 | Human Cytomegalovirus dysregulation of host hematopoietic progenitor cell signaling pathways to modulate latency and reactivation | 3 | 2025 |
1 to 10 of 1,099Source NIH's project files
See all 1,099 nih grantsPapers2,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correction to "IER5 Negatively Regulates Cdc25B Expression in HeLa Cells After Gamma Ray Irradiation". | Biomed Res Int | 2026 | 42608995 | PubTator, text mining | PubMed |
| Identification and Validation of an E2F Targets-Related Gene Signature Risk Score Predicting the Prognosis of Patients with Uveal Melanoma. | Ocul Oncol Pathol | 2026 | 42553888 | PubTator, text mining | PubMed |
| Novel CDK-independent function of CDC25 phosphatases in mRNA translation. | EMBO Rep | 2026 | 42448957 | PubTator, text mining | PubMed |
| Differential DNA Methylation and Delirium After Anesthesia and Surgery. | medRxiv | 2026 | 42369472 | PubTator, text mining | PubMed |
| Exploring a critical time window for FOXM1-driven bladder injury in chronic arsenic exposure. | Ecotoxicol Environ Saf | 2026 | 42190387 | PubTator, text mining | PubMed |
| Chemical components from Uncaria gambir (W.Hunter) Roxb. and their preliminary bioactivities in CDC25B phosphatase inhibition and vasodilatory activity. | Nat Prod Res | 2026 | 42176307 | PubTator, text mining | PubMed |
| The Binding of 3-O-Methylfluorescein Phosphate to the Catalytic Domain of the Human CDC25B Phosphatase: A Structural Investigation. | Chembiochem | 2026 | 41906666 | PubTator, text mining | PubMed |
| AI-derived prognostic model identifies high-risk gene signatures in pediatric gliomas. | Front Immunol | 2026 | 41878416 | PubTator, text mining | PubMed |
| A hybrid molecular-imaging model for high-accuracy early colorectal cancer diagnosis. | J Gastrointest Oncol | 2026 | 41816600 | PubTator, text mining | PubMed |
| Paired-Box (PAX) Gene Signatures as a Biomarker of Breast Cancer Progression. | Int J Mol Sci | 2026 | 41752124 | PubTator, text mining | PubMed |
1 to 10 of 2,079
See all 2,079 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/994
GET https://conductscience.org/api/genes/v1/994/patents?page=2